A dual treatment approach consisting of gemcitabine combined with AB Science’s highly selective tyrosine kinase inhibitor masitinib was associated with significant increases in survival among patients with pancreatic cancer and pain, according to recently announced results from a confirmatory Phase III study.
If you are not happy with the results below please do another search
50 search results for:
The U.S. Food and Drug Administration approved BioCryst Pharmaceuticals Inc.’s Orladeyo (berotralstat) for prophylaxis to prevent attacks of hereditary angioedema in adults and young patients 12 years and older.
The Janssen Pharmaceutical Companies of Johnson & Johnson has a presence in more than 80 of the hematology studies presented at the 62nd American Society of Hematology (ASH) Annual Meeting & Exposition in December.
U.S. leaders urgently called on Americans to wear masks and threatened even more drastic stay-at-home orders after deaths from the coronavirus set a single-day record, with two people dying every minute.
Once touted as promising treatments and by some even a cure, the World Health Organization dashes those claims, finding no benefit in the use of four popular Covid-19 treatments (remdesivir, hydroxychloroquine, lopinavir, or interferon-beta-1a) on hospitalized patients.
U.S. infectious disease expert Anthony Fauci said he was reacting to gloating by a British television interviewer when he criticized the country’s quick approval of the first coronavirus vaccine.
The United States set single-day records for new infections and deaths as California’s governor said he would impose some of the nation’s strictest stay-at-home orders in the coming days when intensive care units are expected to reach capacity.
Moderna Inc. expects to have between 100 million and 125 million doses of the company’s Covid-19 vaccine available globally in the first quarter of 2021.
Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), noted that it would take time – possibly months – before people 18 years of age and younger could get a Covid-19 vaccine because clinical trials were either underway or had not yet begun.
Paris-based Ipsen secured Fast Track designation from the U.S. Food and Drug Administration for Onivyde (irinotecan liposome injection) for study patients with small cell lung cancer (SCLC) who progressed following a first-line platinum-based regimen.